European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis
Wollenberg, A; Flohr, C; Simon, D; Cork, M J; Thyssen, J P; Bieber, T; de Bruin-Weller, M S; Weidinger, S; Deleuran, M; Taieb, A; Paul, C; Trzeciak, M; Werfel, T; Seneschal, J; Barbarot, S; Darsow, U; Torrelo, A; Stalder, J-F; Svensson, Å; Hijnen, D; Gelmetti, C; Szalai, Z; Gieler, U; De Raeve, L; Kunz, B; Spuls, P; von Kobyletzki, L B; Fölster-Holst, R; Chernyshov, P V; Christen-Zaech, S; Heratizadeh, A; Ring, J; Vestergaard, C
(2020) JEADV : journal of the European Academy of Dermatology and Venereology, volume 34, issue 6, pp. e241 - e242
(Comment)
Download/Full Text
The full text of this publication is not available.
Keywords: Advisory Committees, COVID-19, Comorbidity, Coronavirus Infections/epidemiology, Dermatitis, Atopic/drug therapy, Europe, Female, Humans, Immunocompromised Host/drug effects, Immunosuppressive Agents/therapeutic use, Male, Pandemics, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic, Risk Assessment, Severe Acute Respiratory Syndrome/epidemiology, Treatment Outcome, Letter, Review
ISSN: 0926-9959
Publisher: Wiley-Blackwell
Note: Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
(Peer reviewed)